ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RONALD ROMANO DO

Internal Medicine

4,069

$161K

261
209 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

FRANK BAFFONI MD

Internal Medicine

5,086

$156K

257
235 are 65+

N/A

5%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$31
Average prescription price

Avg: $51

RICHARD DELSESTO MD

Internal Medicine

3,507

$139K

140
117 are 65+

N/A
N/A

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

JOSEPH DILORENZO MMSC., M,D,

Internal Medicine

2,475

$126K

100
81 are 65+

N/A

38%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

CHARLENE ELLSWORTH MD

Internal Medicine

2,099

$122K

205
115 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $51

WILLIAM PALUMBO MD

Internal Medicine

1,531

$114K

107
75 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $51

MICHAEL NISSENSOHN M.D.

Internal Medicine

914

$72.9K

165
105 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$80
Average prescription price

Avg: $51

USHA KUMAR M.D

Internal Medicine

2,172

$64.1K

126
118 are 65+

N/A
N/A

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$30
Average prescription price

Avg: $51

ROBERT VELASCO M.D.

Internal Medicine

813

$48.7K

54
29 are 65+

N/A
N/A

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $51

MICHELE YAMAMOTO M.D.

Internal Medicine

711

$31.3K

45
27 are 65+

N/A
N/A

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

CHI-KUANG LAI MD

Internal Medicine

662

$14.2K

395
269 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 22%

$21
Average prescription price

Avg: $51

HUGO YAMADA MD

Internal Medicine

16,238

$1.03M

593
495 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $51

CHRISTOPHER SUPERCZYNSKI M.D.

Internal Medicine

21,901

$981K

1024
858 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

FRANK MAGGIACOMO D.O.

Internal Medicine

17,678

$894K

760
578 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

HERMAN AYVAZYAN MD

Internal Medicine

13,265

$697K

531
445 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

WALTER HOLLINGER

Internal Medicine

10,495

$690K

754
414 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $51

FREDERICK CRISAFULLI MD

Internal Medicine

12,149

$689K

722
633 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $51

PETER ELLER M.D.

Internal Medicine

13,597

$677K

624
558 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

JOB SANDOVAL MD

Internal Medicine

17,471

$653K

686
626 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

DONALD MCNIECE MD

Internal Medicine

13,551

$595K

632
593 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

JOHN MISKOVSKY MD

Internal Medicine

7,513

$595K

318
240 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$79
Average prescription price

Avg: $51

KIMBERLY HUMULOCK DO

Internal Medicine

13,144

$577K

429
369 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

JEFFRY WINTERS MD

Internal Medicine

13,997

$571K

687
585 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $51

PARUL SHAH MD

Internal Medicine

11,770

$545K

432
335 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $51

AMIR ALIZADEH,MD INC. MD

Internal Medicine

14,991

$534K

592
534 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank